MS app study pulled before it even started

NCT ID NCT06309173

Terminated Knowledge-focused Sponsor: Research Center for Clinical Neuroimmunology and Neuroscience Basel Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to test whether a smartphone app could track multiple sclerosis (MS) symptoms and progression remotely. It planned to enroll adults with MS across different countries to see if digital measurements matched standard clinical tests. However, the study was withdrawn before any participants were enrolled, so no results are available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS

Contacts and locations

Show contact details

Locations

Innsbruck Medical University, Department of Neurology

Innsbruck, Tyrol, 6020, Austria
University of California, San Francisco (UCSF) Weill Institute, Department of Neurology

San Francisco, California, 94158, United States
Vienna Medical University, Department of Neurology

Vienna, State of Vienna, 1090, Austria